Crohn's disease: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

No stopped trial with a stated reason in this view.

Trials whose registry record says individual participant data (IPD) will be shared.

• A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008)

  2024-518296-56-00· Merck Sharp & Dohme LLC· Source

• A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease

  NCT07298421· Hoffmann-La Roche· Source

• Oral N-acetylglucosamine in Crohn's Disease

  NCT07225998· Johns Hopkins University· Source

• A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

  NCT07483099· Eli Lilly and Company· Source

• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  NCT06937099· Eli Lilly and Company· Source

• A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

  NCT07483073· Eli Lilly and Company· Source

• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT05242471· Janssen Research & Development, LLC· Source

• A Study of Continued Use of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis in Real World Setting

  NCT07746765· Janssen Sciences Ireland UC· Source

• A Long-term Extension Study of Ustekinumab in Pediatric Participants

  NCT05092269· Janssen Research & Development, LLC· Source

• A Real-World Study of Guselkumab Persistence and Effectiveness in Participants With Crohn's Disease or Ulcerative Colitis

  NCT07848737· Janssen-Cilag, S.A.· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 21
• Organoids 13
• Mendelian Randomization Analysis 44
• Gene Expression Profiling 48
• Sequence Analysis, RNA 6
• Exome Sequencing 4
• Proteomics 14
• Metabolomics 23
• Mass Spectrometry 5
• Flow Cytometry 6
• Immunohistochemistry 9
• Positron-Emission Tomography 3
• Magnetic Resonance Imaging 75
• Machine Learning 36
• Deep Learning 13
• Cohort Studies 96
• Genome-Wide Association Study 58

See which targets of this disease your abstract mentions, and go to the people working on them.